BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ·Healthcare·Biotechnology
$61.51
-0.89%
Mkt Cap $11.47B
Analyst Ratings
Buy
16
Hold
4
Sell
0
Price Target (66 analysts)
$89.21
Range $50.00 – $120.00
Implied Upside
+45.0%
Consensus $89.21 vs current $61.51
NASDAQ·Healthcare·Biotechnology
$61.51
-0.89%
Mkt Cap $11.47B
Buy
16
Hold
4
Sell
0
Price Target (66 analysts)
$89.21
Range $50.00 – $120.00
+45.0%
Consensus $89.21 vs current $61.51